siRNA Treatment: “A Sword-in-the-Stone” for Acute Brain Injuries

Ever since the discovery of small interfering ribonucleic acid (siRNA) a little over a decade ago, it has been highly sought after for its potential as a therapeutic agent for many diseases. In this review, we discuss the promising possibility of siRNA to be used as a drug to treat acute brain injur...

Full description

Bibliographic Details
Main Authors: Jerome Badaut, Andrew M. Fukuda
Format: Article
Language:English
Published: MDPI AG 2013-09-01
Series:Genes
Subjects:
Online Access:http://www.mdpi.com/2073-4425/4/3/435
id doaj-279a53f25eec422a8fe62a6adbfebb16
record_format Article
spelling doaj-279a53f25eec422a8fe62a6adbfebb162020-11-24T20:56:14ZengMDPI AGGenes2073-44252013-09-014343545610.3390/genes4030435siRNA Treatment: “A Sword-in-the-Stone” for Acute Brain InjuriesJerome BadautAndrew M. FukudaEver since the discovery of small interfering ribonucleic acid (siRNA) a little over a decade ago, it has been highly sought after for its potential as a therapeutic agent for many diseases. In this review, we discuss the promising possibility of siRNA to be used as a drug to treat acute brain injuries such as stroke and traumatic brain injury. First, we will give a brief and basic overview of the principle of RNA interference as an effective mechanism to decrease specific protein expression. Then, we will review recent in vivo studies describing siRNA research experiments/treatment options for acute brain diseases. Lastly, we will discuss the future of siRNA as a clinical therapeutic strategy against brain diseases and injuries, while addressing the current obstacles to effective brain delivery.http://www.mdpi.com/2073-4425/4/3/435brainsiRNARNAitraumatic brain injurystrokeischemiasubarachnoid hemorrhage
collection DOAJ
language English
format Article
sources DOAJ
author Jerome Badaut
Andrew M. Fukuda
spellingShingle Jerome Badaut
Andrew M. Fukuda
siRNA Treatment: “A Sword-in-the-Stone” for Acute Brain Injuries
Genes
brain
siRNA
RNAi
traumatic brain injury
stroke
ischemia
subarachnoid hemorrhage
author_facet Jerome Badaut
Andrew M. Fukuda
author_sort Jerome Badaut
title siRNA Treatment: “A Sword-in-the-Stone” for Acute Brain Injuries
title_short siRNA Treatment: “A Sword-in-the-Stone” for Acute Brain Injuries
title_full siRNA Treatment: “A Sword-in-the-Stone” for Acute Brain Injuries
title_fullStr siRNA Treatment: “A Sword-in-the-Stone” for Acute Brain Injuries
title_full_unstemmed siRNA Treatment: “A Sword-in-the-Stone” for Acute Brain Injuries
title_sort sirna treatment: “a sword-in-the-stone” for acute brain injuries
publisher MDPI AG
series Genes
issn 2073-4425
publishDate 2013-09-01
description Ever since the discovery of small interfering ribonucleic acid (siRNA) a little over a decade ago, it has been highly sought after for its potential as a therapeutic agent for many diseases. In this review, we discuss the promising possibility of siRNA to be used as a drug to treat acute brain injuries such as stroke and traumatic brain injury. First, we will give a brief and basic overview of the principle of RNA interference as an effective mechanism to decrease specific protein expression. Then, we will review recent in vivo studies describing siRNA research experiments/treatment options for acute brain diseases. Lastly, we will discuss the future of siRNA as a clinical therapeutic strategy against brain diseases and injuries, while addressing the current obstacles to effective brain delivery.
topic brain
siRNA
RNAi
traumatic brain injury
stroke
ischemia
subarachnoid hemorrhage
url http://www.mdpi.com/2073-4425/4/3/435
work_keys_str_mv AT jeromebadaut sirnatreatmentaswordinthestoneforacutebraininjuries
AT andrewmfukuda sirnatreatmentaswordinthestoneforacutebraininjuries
_version_ 1716790310293471232